...
首页> 外文期刊>Biological & pharmaceutical bulletin >Differential cytotoxicity of anticancer agents in pre- and post-immortal lymphoblastoid cell lines.
【24h】

Differential cytotoxicity of anticancer agents in pre- and post-immortal lymphoblastoid cell lines.

机译:永生前和永生后淋巴母细胞样细胞系中抗癌药的细胞毒性差异。

获取原文
获取原文并翻译 | 示例
           

摘要

We studied the cytotoxic effect of various anticancer agents on lymphoblastoid cell lines transformed by Epstein-Barr virus. Post-immortal N0005 (post-N0005) is an immortalized cell line derived from pre-immortal N0005 (pre-N0005) accompanied by increased telomerase activity, short-telomere, abnormal karyotypes, mutation of p53 gene, down regulation of p16/Rb and the ability to grow in soft agar medium. Compared with pre-N0005 cells, post-N0005 cells were significantly (p<0.001 by the Student t test) more resistant to the killing activity of seven DNA-modifying agents: camptothecin, etoposide, bleomycin, fluorouracil, thioguanine, melphalan and actinomycin D. However, both pre-N0005 and post-N0005 cells showed similar levels of cytotoxicity against four DNA-non-modifying agents: colchicine, paclitaxel, vincristine and methotrexate. DNA-modifying and DNA-non-modifying agents are distinguished by their different sensitivities with pre-N0005 and post-N0005. Based on these results, we propose that pre-N0005 and post-N0005 cell lines be used as a new method to assess and screen anticancer agents.
机译:我们研究了各种抗癌剂对由爱泼斯坦-巴尔病毒转化的淋巴母细胞系的细胞毒作用。永生后N0005(N0005后)是永生前N0005(N0005前)衍生的永生化细胞系,伴随着端粒酶活性增加,端粒短,核型异常,p53基因突变,p16 / Rb的下调和在软琼脂培养基中生长的能力。与N0005之前的细胞相比,N0005之后的细胞对7种DNA修饰剂(喜树碱,依托泊苷,博来霉素,氟尿嘧啶,硫鸟嘌呤,美法仑和放线菌素D)的杀伤活性具有显着的抗性(通过Student t检验,p <0.001)。但是,N0005之前和N0005之后的细胞对四种DNA非修饰剂:秋水仙碱,紫杉醇,长春新碱和氨甲蝶呤的细胞毒性水平相似。 DNA修饰剂和DNA非修饰剂的区别在于N0005之前和N0005之后的敏感性不同。基于这些结果,我们建议将N0005之前和N0005之后的细胞系用作评估和筛选抗癌药物的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号